Cara Therapeutics to Present at the Jefferies 2019 Healthcare Conference
May 31 2019 - 7:00AM
Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical
company focused on developing and commercializing new chemical
entities with a primary focus on pruritus by selectively targeting
peripheral kappa opioid receptors, today announced a Company
presentation at the Jefferies 2019 Healthcare Conference on
Wednesday, June 5, 2019 at 9:30 a.m. ET in New York, NY.
A live webcast of the presentation can be
accessed under "Events & Presentations" in the News &
Investors section of the Company's website
at www.CaraTherapeutics.com. An archived webcast recording
will be available on the Cara website for approximately 30
days.
About Cara Therapeutics
Cara Therapeutics is a clinical-stage
biopharmaceutical company focused on developing and commercializing
new chemical entities designed to alleviate pruritus by selectively
targeting peripheral kappa opioid receptors (KORs). Cara is
developing a novel and proprietary class of product candidates, led
by KORSUVA™ (CR845/difelikefalin), a first-in-class KOR agonist
that targets the body's peripheral nervous system, as well as
certain immune cells. In a Phase 3 trial and Phase 2 trials,
KORSUVA injection has demonstrated statistically significant
reductions in itch intensity and concomitant improvement in quality
of life measures in hemodialysis patients with moderate-to-severe
chronic kidney disease-associated pruritus (CKD-aP), and is
currently being investigated in Phase 3 trials in hemodialysis
patients with CKD-aP.
The FDA has conditionally accepted KORSUVA™ as
the trade name for difelikefalin injection. CR845/difelikefalin is
an investigational drug product and its safety and efficacy have
not been fully evaluated by any regulatory authority.
INVESTOR CONTACT:Michael SchaffzinStern
Investor Relations, Inc. 212-362-1200
michael.schaffzin@sternir.com
MEDIA CONTACT:Annie Starr6
Degrees973-415-8838astarr@6degreespr.com
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Apr 2023 to Apr 2024